Jardiance

Here comes Steglatro. Free

 

Jardiance is the new Pradaxa- We have the CV data so therefore everybody should rx. Let's cut our speakers, cut T&E, lose CVS (don't worry those docs are going to do PAs no prob). BI is incredibly naive,stupid,or desperate for short term profits (maybe all of the above).
When in the history of pharma has a new market leader cut their resources? Totally bizarre!

 

Get back to work you Filthy Animal. These challenges simply make it a sales person’s job. Not covered- then use cover my meds. No CMM. No problem talk up the fine point that the patient should be willing to pay out of pocket for this crap!
The TBLs will rally the troops and limit samples so you slackers have to sell!
Don’t like it - hit the bricks!

 

He's very passionate, about what I have no idea! (RIP Rodney)

 

Don’t worry, your amputation data will chop any ideas of growth just like no-toes-kana!

 

In the end, it will be seen that we should have just played ball with Caremark. What we may ‘save’ in rebates will will more than lose in terms of lost sales, costs for push through to CMM as well as copay card adjudication.

Not to mention the ‘loss’ from what utilization we lose from other plans.

 

It's amazing BI doesn't get law of unintended consequences. Any first year rep could tell you that if you lose a big plan the drs. perception is going to be it's not covered on any plans.

 

True, but unless it can be actually quantified, the brand team will not make decisions based on ‘unintended consequences.’ There must be a measurable impact that the brand can use to determine which course to take.

 

The docs only care that Steglatro is free. Great job Pfizer

 

Steglatro is kicking ass in Mississippi

 

Extra RIP to the late great Sam Kinison in Back to School. Great movie!

 

Are you really talking about a drug that you’re competing with named after a prehistoric vegetarian dinosaur? Seriously? Get out. Leave primary care. BI is a joke show.

 

I find this statement hard to believe it’s kicking anything given it warns of leg amputations when using it. Just saying.

 

their PI says there is no association between steglatro and amputations
pretty strong statement from fad

 

in the STEGLATRO development program, non-traumatic lower limb amputations were reported in 1 (0.1%) patient in thecomparator group, 3 (0.2%) patients in the STEGLATRO5 mg group, and 8 (0.5%) patients in the STEGLATRO 15 mg

 

BI is sooo frustrating to work for.
I swear we have a great drug in Jardiance but it’s like the company doesn’t wanna win. They wanna be cheap and just do ok.

Wtf ever. I’m over it. Y’all dint wanna won then I’m just gonna do the check the boxes to say I did my job

 

Ditto that feeling. Im going to keep working it but very frustrating. Lilly is worthless too.

 

Farxiga is picking up and the oral GLP1 is coming......,2019 was a piece of cake. 2020 is gonna hurt!

 

It’s about time. Respiratory can’t have all the “fun”.

 

IKR!! Pain is coming.